C ystic fibrosis (CF) is caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene that encodes a protein kinase A (PKA)-activated chloride (Cl Ϫ ) channel. In the absence of functional CFTR, defective Cl Ϫ secretion impairs mucociliary clearance and results in viscous secretions in which bacteria proliferate, leading to an influx of immune cells (1, 2) . The subsequent robust inflammatory response contributes significantly to airway destruction, respiratory failure, and shortened life expectancy. Recent reports suggest that airway inflammation occurs early in life and can be observed before bacterial colonization. Increased numbers of neutrophils and increased IL-8, which may be partially macrophage-derived, have been noted without concomitant infection in the bronchoalveolar lavage (BAL) fluid of infants with CF (3). These findings suggest that if inflammation is present before infection, then macrophages may be important in stimulating the influx of neutrophils into the airways of these patients. Hubeau et al. (4) provided additional evidence that macrophages may contribute to this process as they reported increased numbers of macrophages in CF-affected fetal lung tissue in the absence of acute infection or concurrent increase in other immune cells or inflammatory markers. As macrophages are responsible for recruitment of immune cells to sites of inflammation, macrophage dysfunction in CF may result in altered responses to pathogenic stimuli.
If macrophage dysfunction contributes to the robust inflammatory response described in CF, it may be due to impaired Cl Ϫ transport, similar to the mechanism that underlies the pathology observed in CF-affected epithelia. Cl Ϫ flux has been described in macrophages at rest (5, 6) , during phagocytosis (7), after stimulation when it is associated with increased intracellular calcium (Ca 2ϩ ) levels (8) , and during macrophage activation when it is accompanied by changes in membrane potential. Despite these reports, the exact Cl Ϫ pathways and their roles in macrophage function have not been fully defined.
The aim of this study was to evaluate the Cl Ϫ efflux pathways present in macrophages. More specifically, to define the contributions of CFTR and Ca 2ϩ -activated Cl Ϫ pathways to total Cl Ϫ flux. Although CFTR activity has been reported in WT macrophages (9), its functional significance remains a question that requires further investigation. In addition, up-regulation of Ca 2ϩ -activated Cl Ϫ channels (CaCCs) has been well described in airway epithelia in the absence of functional CFTR (10), but it is unknown whether this relationship exists in nonepithelial cells. If this relationship is present in macrophages, then it may represent a potential pathway that can be targeted for novel therapeutic intervention. Cl Ϫ efflux was studied in murine bone marrowderived (BMD) WT and CF macrophages to compare the contribution of these Cl Ϫ efflux pathways to total Cl Ϫ transport.
METHODS

Animals.
For all experiments outlined, two murine models of CF were used: a ⌬F508 model (Cftr tm1Kt ) (11) and a cftr Ϫ/Ϫ model (Cftr tm1UNC ) (12) . Both models have been fully backcrossed on a Bl6 background. They were bred and maintained as previously described (13) (14) (15) . All procedures were performed in accordance with protocols approved by the Yale University Institutional Animal Care and Use Committee.
BMD macrophage isolation. BM was obtained from long bones (hip, femur, and tibia) of mice (2-4 mo). Monocytic precursors were selected via Histopaque gradient. Following overnight culture, nonadherent macrophages were selectively grown in DMEM media (Invitrogen, Carlsbad, CA) with 10% FCS, L-glutamine, penicillin/streptomycin (100,000 units/mL), and 20 ng/mL recombinant murine macrophage colony stimulating factor (PeproTech Inc., Rocky Hill, NJ). Macrophages were cultured at 37°C with 5% CO 2 for 9 -14 d and then harvested with Neutral Protease (Worthington Co., Lakewood, NJ); 5-30 ϫ 10 6 cells were obtained/mouse. Cultured macrophages are F480ϩ/MAC-1ϩ as confirmed by flow cytometry (16 (18) . Dye loading and subsequent experimentation were performed in a custom perfusion chamber mounted on an Olympus IX-71 inverted microscope (19) . MQAE was excited at 354 Ϯ 10 nm, and emitted fluorescent light was measured at 460 Ϯ 10 nm every 5 s using a charge coupled device camera attached to a digital imaging system (20, 21 concentrations (22) (23) (24) (25) . The high Ca 2ϩ /Cl Ϫ -free solution had a Ca 2ϩ concentration of 2 mM, which can be found in tracheobronchial secretions (26, 27) . Macrophages were assessed in a low Ca 2ϩ (0.1 mM)/Cl Ϫ -free solution for comparison. To ensure that the extracellular Ca 2ϩ concentrations did not affect cell viability, assays were performed with Trypan blue in each experimental solution demonstrating Ն90% viability. Solutions were adjusted to a final pH of 7.4 at 37°C and an osmolarity of 300 mOsmol.
To confirm the presence of Cl Ϫ movement, macrophages were assessed in the presence of 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB, 100 M), a broad inhibitor of Cl Ϫ channels (28), as cells transitioned from Cl Ϫ -containing to Cl Ϫ -free solutions. The contribution of CFTR to total Cl Ϫ efflux after treatment with either inhibitor were compared with rates of Cl Ϫ efflux observed in the absence of the inhibitors. Vehicles alone (ethanol or DMSO) had no effect on efflux.
The effect of increasing intracellular Ca 2ϩ concentrations on Cl Ϫ efflux was assessed indirectly after treatment with either carbachol or thapsigargin. Macrophages were treated with carbachol (100 M) for 30 min, while loading with MQAE (29) . Alternatively, macrophages were assessed after treatment with thapsigargin (1 M) for 2 min in Cl Ϫ -containing solution before assessment in Cl Ϫ -free solution. After treatment with either agent, Cl Ϫ efflux was assessed in either low Ca 2ϩ /Cl Ϫ -free solution with addition of EGTA (1 mM) or in the control solution. Chemicals were purchased from Sigma Chemical Co. Corporation unless specified. 
Data analysis. Maximal apparent Cl
Ϫ efflux was calculated using GraphPad Prism version 5.01 for Windows (GraphPad Software, San Diego, CA) in conjunction with Microsoft Excel to compute the first derivative of the change in MQAE fluorescence over time (slope). The data are summarized as the mean Cl Ϫ efflux (⌬AFU/⌬s) Ϯ the SEM. An unpaired t test with Welch's correction (accounting for unequal variances) was performed to compare slopes between experimental conditions. A p value of Ͻ0.05 was considered statistically significant.
RESULTS
Chloride efflux is present in both CF-affected and WT macrophages. Changes in MQAE fluorescence in Cl Ϫ -containing and control Cl Ϫ -free solutions for both WT and CF macrophages are represented in Figure 1 . Cl Ϫ efflux, calculated as the rate of change in MQAE fluorescence (⌬AFU/⌬s), was present in both genotypes. Cl Ϫ efflux was confirmed via the absence of flux in both WT and CF macrophages in the presence of NPPB (Fig. 2) . The mean Cl Ϫ efflux (⌬AFU/⌬s) was calculated for comparison between genotypes in control Cl Ϫ -free solution (Fig. 3) . The Cl Ϫ efflux observed in WT macrophages (9.21 Ϯ 0.51 AFU/s) was significantly greater than CF macrophages (Fig. 4) . In contrast, cftr inh -172 had no appreciable effects on Cl Ϫ efflux in CF macrophages (3.9 Ϯ 0.23 AFU/s, p ϭ 0.09). Of note, in the presence of cftr inh -172, the rate of Cl Ϫ efflux observed in WT macrophages was equivalent to the rate observed in CF macrophages (p ϭ 0.15).
The presence of Cl Ϫ efflux in CF and WT macrophages after treatment with cftr inh -172 suggests that non-CFTRdependent Cl Ϫ pathways contributed to total Cl Ϫ efflux in macrophages. Previous studies in CF-affected epithelia have described an up-regulation of CaCCs (10) Figure 5A . In contrast, only CF-affected macrophages demonstrated a significant increase in Cl Ϫ efflux in high (2 mM) Ca 2ϩ solution (6.86 Ϯ 0.4 AFU/s, p ϭ 0.0002; Fig. 5B ). Similar changes were not observed in WT macrophages (7.64 Ϯ 0.67 AFU/s, p ϭ 0.12).
Because extracellular Ca 2ϩ can ultimately affect intracellular Ca 2ϩ levels, the effects of altering intracellular Ca 2ϩ concentrations on Cl Ϫ efflux were subsequently assessed. Macrophages were exposed to carbachol, a combined muscarinic and nicotinic receptor agonist that stimulates Ca 2ϩ release from intracellular stores (30) . In addition, macrophages were exposed to thapsigargin, a sarco(endo)plasmic reticulum Ca 2ϩ ATPase (SERCA) pump inhibitor that prevents Ca To confirm that the changes in Cl Ϫ flux observed after carbachol treatment were due to increased intracellular Ca 2ϩ concentration rather than nonspecific effects, macrophages were assessed after treatment with thapsigargin. As shown in Figure 6B , Cl Ϫ efflux was significantly augmented in CF Finally, to assess whether Ca 2ϩ entry contributed to the observed increase in Cl Ϫ efflux, macrophages were assessed after treatments with either carbachol (Fig. 7A) or thapsigargin (Fig. 7B) , while being perfused with a low extracellular Ca 2ϩ solution containing EGTA (1 mM) to chelate external Ca 2ϩ available. In the low Ca 2ϩ solution, only CF macrophages demonstrated significant enhancement of Cl Ϫ efflux after treatment with carbachol (9.03 Ϯ 0.55 AFU/s, p Ͻ 0.0001) and thapsigargin (13.82 Ϯ 0.91 AFU/s, p Ͻ 0.0001). Interestingly, the rate of Cl Ϫ efflux observed in CF macrophages after thapsigargin treatment was greater than that observed in WT macrophages under all conditions studied. In contrast, rates of Cl Ϫ efflux were not similarly increased in WT macrophages after treatment with either carbachol (8.47 Ϯ 0.96 AFU/s, p ϭ 0.723) or thapsigargin (10.41 Ϯ 0.69 AFU/s, p ϭ 0.056). Taken together, these data suggest that it is unlikely Ca 2ϩ entry significantly contributed or modulated the rates of Cl Ϫ efflux observed after carbachol or thapsigargin treatments.
DISCUSSION
CF has been described as a disease of the epithelia (32). However, the possibility that CFTR dysfunction affects non- epithelial cells, including primary immune cells, has been raised on numerous occasions (1, 2) . For instance, the BAL specimens from asymptomatic CF infants demonstrate increased levels of IL-8 that could be macrophage-derived (3). In addition, BAL specimens from older patients with CF demonstrate increased numbers of macrophages in combination with increased levels of chemokines, known to attract peripheral monocytes (33) . In addition, after stimulation with lipopolysaccharide, CF mice exhibit increased levels of BAL cytokines, that are largely macrophage-derived, compared with WT littermates (16) . Moreover, comparable abnormalities of cytokine secretion are observed in their BMD macrophages (16, 34) . These data suggest that there is a primary defect in CFTR-deficient monocytes that results in their increased activation. Despite these reports, there is no consensus that CFTR dysfunction directly contributes to these findings and thus the role of CFTR in macrophages remains speculative.
Reports suggest that ion channel conductances likely influence immune cell function (35) (39 -41) . One could speculate that under certain circumstances, such as an acute inflammatory response, extracellular Ca 2ϩ levels, which range from 1 to 4 mM in tracheobronchial secretions, could result in a more robust Cl Ϫ efflux in these CF macrophages to enhance their function.
However, the use of Ca 2ϩ -modulated Cl Ϫ pathways could also be detrimental in the overall CF inflammatory response. For instance, studies indicate that changes in Ca 2ϩ mobilization and homeostasis within CF airway epithelia are linked with its predisposition to a hyperinflammatory phenotype (42) (43) (44) (45) . In addition, Mueller et al. (46) recently described that altered intracellular Ca 2ϩ mobilization in cftr Ϫ/Ϫ lymphocytes led to the induction of inflammatory signaling pathways and cytokine secretion. Thus, the enhancement of Ca 2ϩ -modulated Cl Ϫ efflux pathways in our CF macrophages may be a potential mechanism by which macrophages directly contribute to the hyperinflammatory phenotype and airway pathophysiology observed in CF.
